
Reset all filters
01 1BYETTA
02 1BYNFEZIA PEN
03 1CETROTIDE
04 2COPAXONE
05 1EGRIFTA
06 1NOVOLOG MIX 70/30
07 1NOVOLOG MIX 70/30 FLEXPEN
08 1NOVOLOG MIX 70/30 PENFILL
09 1SIGNIFOR
10 1SOGROYA
11 1SOMAVERT
12 1SYMLIN
Reset all filters
01 220622
02 121106
03 321172
04 121197
05 121332
06 121773
07 122505
08 1200677
09 1213224
10 1761156
Reset all filters
01 11No
02 2Yes
Drug : BYETTA
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21773
Country : US
Patented : No
Drug : SYMLIN
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21332
Country : US
Patented : No
Drug : CETROTIDE
Dosage Form : POWDER; SUBCUTANEOUS
Application Number : 21197
Country : US
Patented : No
Drug : SOGROYA
Dosage Form : SOLUTION; SUBCUTANEOUS
Application Number : 761156
Country : US
Patented : No
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Drug : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21172
Country : US
Patented : No
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Drug : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21172
Country : US
Patented : No
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Drug : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21172
Country : US
Patented : No
Drug : SOMAVERT
Dosage Form : INJECTABLE; SUBCUTANEOUS
Application Number : 21106
Country : US
Patented : No
Drug : SIGNIFOR
Dosage Form : SOLUTION; SUBCUTANEOUS
Application Number : 200677
Country : US
Patented : Yes
Drug : EGRIFTA
Dosage Form : POWDER; SUBCUTANEOUS
Application Number : 22505
Country : US
Patented : No